Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma von Jain, Rohit K., Yang, Yuanquan (Aaron), Chadha, Juskaran, Zhang, Jingsong, Raymond, Sarah, Oschmann, Erika, Poehlman, Trey, Fan, Wenyi, Kim, Youngchul, Dhillon, Jasreman, Chahoud, Jad, Chatwal, Monica Sheila, Sonpavde, Guru P.

Volltext

A phase 2 study of the combination dostarlimab with niraparib in patients with penile carcinoma that has progressed following chemotherapy von Neubauer, Robin, Pettaway, Curtis Alvin, Spiess, Philippe E., Jain, Rohit K., Chadha, Juskaran, Zhang, Jingsong, Chahoud, Jad, Roman Souza, Gabriel, Dhillon, Jasreman, Moscu, Anay, Janeway, Ryan, Harris, David Walter, Lu, Xin, Jameel, Ghazal, Raymond, Sarah, Oschmann, Erika, Kim, Youngchul, Campbell, Matthew T, Schuckman, Anne K.

Volltext